mineralocorticoid receptor antagonists | Department of Medicine Blog

Social Determinants of Health and Disparities in Guideline-Directed Medical Therapy Optimization for Heart Failure

Jacobs JA, Ayodele I, Bress AP, Sterling MR, Pandey A, Derington CG, Zheutlin AR, Shah KS, Greene SJ, Alhanti B, Blanco R, Fonarow GC. Social[...]

By sjmartinez • November 14, 2024

Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trial

Schou M, Claggett B, Miao ZM, Fernandez A, Filippatos G, Granger C, Jering K, Maggioni AP, McCausland F, Villota JN, Rouleau JL, Mody FV, van[...]

By sjmartinez • February 21, 2024

STRONG-HF and Implementing Heart Failure Therapies: Godspeed … With Care

Butler J, Talha KM, Fonarow GC. STRONG-HF and Implementing Heart Failure Therapies: Godspeed … With Care. Circulation. 2023 Apr 18;147(16):1189-1191. doi: 10.1161/CIRCULATIONAHA.122.063811. Epub 2023 Apr[...]

By sjmartinez • April 19, 2023